← Back to Search

Light Therapy

Transcranial LED Therapy (Participants ages 9-17) for Autism Spectrum Disorder

N/A
Waitlist Available
Led By Tolga A Ceranoglu, MD
Research Sponsored by Massachusetts General Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 8 weeks
Awards & highlights

Study Summary

This trial is meant to study whether Transcranial LED Therapy is a safe and tolerable treatment for ASD symptoms and to what extent it may improve symptoms and quality of life.

Eligible Conditions
  • Autism Spectrum Disorder
  • Autism

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~8 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 8 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in ASD Symptoms Social Responsiveness Scale 2 (SRS-2) Scale.
Number of Participants With CGI Improvement Scores of ≤ 2 at Week 8

Trial Design

2Treatment groups
Experimental Treatment
Group I: Transcranial LED Therapy (Participants ages 9-17)Experimental Treatment1 Intervention
Transcranial Laser Emitting Diode (LED) Therapy (TLT) is a noninvasive intervention in which near-infrared light (830nm-850nm) is applied to forebrain.
Group II: Transcranial LED Therapy (Participants ages 18-59)Experimental Treatment1 Intervention
Transcranial Laser Emitting Diode (LED) Therapy (TLT) is a noninvasive intervention in which near-infrared light (830nm-850nm) is applied to forebrain.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Transcranial LED Therapy (Participants ages 18-59)
2017
N/A
~20
Transcranial LED Therapy (Participants ages 9-17)
2017
N/A
~20

Find a Location

Who is running the clinical trial?

Massachusetts General HospitalLead Sponsor
2,932 Previous Clinical Trials
13,198,483 Total Patients Enrolled
42 Trials studying Autism Spectrum Disorder
3,116 Patients Enrolled for Autism Spectrum Disorder
Tolga A Ceranoglu, MDPrincipal Investigator - Massachusetts General Hospital
Massachusetts General Hospital

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this research program currently enrolling new participants?

"Clinicaltrials.gov data suggests that this trial is no longer inducting participants, with the last update being on September 28th 2022 after it was initially published on April 13th 2017. Nevertheless, there are presently 279 other clinical trials recruiting patients at this time."

Answered by AI

Are adolescents eligible to participate in this research study?

"Complying with the criteria for this clinical trial, only those between 18 and 59 years of age are eligible to participate."

Answered by AI

Do I meet the qualifications to join this clinical experiment?

"This clinical trial requires 30 participants, of legal age (18-59) to be diagnosed with autism spectrum disorder. Applicants must also fulfil DSM-5 criteria and have moderately severe ASD symptoms as demonstrated by SRS-2 raw score ≥85 and CGI-ASD severity score ≥4; demonstrate understanding of the study's purpose; have no major psychiatric disorders that would exclude them from participation; use a double barrier method for contraception if sexually active; and willingly partake in this research project."

Answered by AI

Who else is applying?

What state do they live in?
New York
Pennsylvania
How old are they?
18 - 65
What portion of applicants met pre-screening criteria?
Did not meet criteria
Recent research and studies
clinicaltrials.govStudy
Photobiomodulation in Autism Spectrum Disorder (ASD)
Tolga A Ceranoglu 2017. "Photobiomodulation in Autism Spectrum Disorder (ASD)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03724552.
~1 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top